Presepsin (sCD14-ST), an innate immune response marker in sepsis

Bone, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest, 101, 1644, 10.1378/chest.101.6.1644 Pierrakos, 2010, Sepsis biomarkers: a review, Crit. Care, 14, R15, 10.1186/cc8872 Nakamura, 2008, Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model, Crit. Care, 12, P194, 10.1186/cc6415 Luzzani, 2003, Comparison of procalcitonin and C-reactive protein as markers of sepsis, Crit. Care Med., 31, 1737, 10.1097/01.CCM.0000063440.19188.ED Tang, 2007, Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis, Lancet Infect. Dis., 7, 210, 10.1016/S1473-3099(07)70052-X Medzhitov, 2000, Innate immunity, N. Engl. J. Med., 343, 338, 10.1056/NEJM200008033430506 Okamura, 2011, Development of a point-of-care assay system for measurement of presepsin (sCD14-ST), Clin. Chim. Acta, 412, 2157, 10.1016/j.cca.2011.07.024 Hancock, 2001, Cationic peptides: effectors in innate immunity and novel antimicrobials, Lancet Infect. Dis., 1, 156, 10.1016/S1473-3099(01)00092-5 Modlin, 1999, The toll of innate immunity on microbial pathogens, N. Engl. J. Med., 340, 1834, 10.1056/NEJM199906103402312 Wright, 1990, CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431, 10.1126/science.1698311 Jack, 1997, Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection, Nature, 389, 742, 10.1038/39622 Zanoni, 2011, CD14 controls the LPS-induced endocytosis of Toll-like receptor 4, Cell, 147, 868, 10.1016/j.cell.2011.09.051 Poussin, 1998, CD-14 dependent endotoxin internalization via a macropinocytic pathway, J. Biol. Chem., 273, 20285, 10.1074/jbc.273.32.20285 Le-Barillec, 1999, Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation, J. Clin. Invest., 103, 1039, 10.1172/JCI5779 Landmann, 1996, Function of soluble CD14 in serum from patients with septic shock, J. Infect. Dis., 173, 661, 10.1093/infdis/173.3.661 Pavcnik-Arnol, 2007, Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children, Intensive Care Med., 33, 1025, 10.1007/s00134-007-0626-y Berner, 2002, Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis, Clin. Diagn. Lab. Immunol., 9, 440 Kitchens, 1998, Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways, J. Immunol., 161, 5534, 10.4049/jimmunol.161.10.5534 Mussap, 2011, Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers, J. Matern. Fetal Neonatal Med., 24, 12, 10.3109/14767058.2011.601923 Rey Nores, 1999, Soluble CD14 acts as a negative regulator of humanT cell activation and function, Eur. J. Immunol., 29, 265, 10.1002/(SICI)1521-4141(199901)29:01<265::AID-IMMU265>3.3.CO;2-7 Landmann, 1995, Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock, J. Infect. Dis., 171, 639, 10.1093/infdis/171.3.639 Yaegashi, 2005, Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis, J. Infect. Chemother., 11, 234, 10.1007/s10156-005-0400-4 Shirakawa, 2011, Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients, Clin. Chem. Lab. Med., 49, 937, 10.1515/CCLM.2011.145 Chenevier-Gobeaux, 2014, Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line, Ann. Biol. Clin. (Paris) Shozushima, 2011, Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome, J. Infect. Chemother., 17, 764, 10.1007/s10156-011-0254-x Claessens, 2013, Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patients, Crit. Care Liu, 2013, Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department, Crit. Care, 17, R244, 10.1186/cc13070 Chenevier-Gobeaux, 2014, Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?, Clin. Chim. Acta, 427, 34, 10.1016/j.cca.2013.09.019 Behnes, 2014, Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment, Crit. Care, 18, 507, 10.1186/s13054-014-0507-z Kweon, 2014, Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population, J. Crit. Care, 29, 965, 10.1016/j.jcrc.2014.06.014 Mussap, 2012, Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges, J. Matern. Fetal Neonatal Med., 25, 51, 10.3109/14767058.2012.717462 Malíčková, 2014, Diagnostic and prognostic value of presepsin in preterm deliveries, J. Matern. Fetal Neonatal Med., 1 Ulla, 2013, Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study, Crit. Care, 17, R16, 10.1186/cc12847 Ishikura, 2014, New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study, Crit. Care, 18, R19, 10.1186/cc13700 Romualdo, 2014, Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department, Clin. Biochem., 47, 505, 10.1016/j.clinbiochem.2014.02.011 Cakır Madenci, 2014, Evaluation of soluble CD14 subtype (presepsin) in burn sepsis, Burns, 40, 664, 10.1016/j.burns.2013.08.024 Mallet-Coste, 2013, Presepsin (sCD14-ST), an emergent and promising biomarker of infection, Ann. Fr. Med. Urgence, 3, 305, 10.1007/s13341-013-0347-5 Clerico, 2009, High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice, Adv. Clin. Chem., 49, 1, 10.1016/S0065-2423(09)49001-2 Januzzi, 2006, NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study, Eur. Heart J., 27, 330, 10.1093/eurheartj/ehi631 Thygesen, 2012, How to use high-sensitivity cardiac troponins in acute cardiac care, Eur. Heart J., 33, 2252, 10.1093/eurheartj/ehs154 Palmiere, 2013, Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the post-mortem diagnosis of sepsis-related fatalities, Int. J. Legal Med., 127, 799, 10.1007/s00414-012-0804-5 Masson, 2014, Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis; data from the Albumin Italian Outcome Sepsis trial, Crit. Care, 18, R6, 10.1186/cc13183 Rabensteiner, 2014, Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome, J. Infect., 69, 627, 10.1016/j.jinf.2014.07.024 Endo, 2014, Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study, J. Infect. Chemother., 20, 30, 10.1016/j.jiac.2013.07.005 Liu, 2014, Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department, Respir. Med., 108, 1204, 10.1016/j.rmed.2014.05.005 Nakamura, 2009, Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unite, Shock, 31, 591, 10.1097/SHK.0b013e31819716fa Takahashi, 2015, Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study, Eur. J. Anaesthesiol., 32, 199, 10.1097/EJA.0000000000000178 Poggi, 2015, Presepsin for the detection of late-onset sepsis in preterm newborns, Pediatrics, 135, 68, 10.1542/peds.2014-1755